Insiders Acarix AB

Equities

Delayed Nasdaq Stockholm Other stock markets 10:36:16 24/05/2024 BST			5-day change	1st Jan Change
0.3145 ^SEK	+0.48%		-0.32%	+65.17%

05-14	Transcript : Acarix AB, Q1 2024 Earnings Call, May 14, 2024
05-14	Acarix AB Approves Board Elections	CI

Acarix AB Approves Board Elections	05-14	CI
Acarix Appoints New Members to the Advisory Board	02-15	CI
Acarix Names New CEO	02-01	MT
Acarix AB Announces CEO Changes	02-01	CI
Acarix CEO to Take Medical Leave; Acting CEO Appointed	03/10/23	MT
Acarix AB Announces CEO Changes	02/10/23	CI
Acarix AB Appoints Christian Lindholm as Executive Vice President	02/10/23	CI
Acarix AB Appoints Dr. Deepak R. Talreja Md as New Medical Advisor	28/08/23	CI
Acarix AB Elects Mikael Thorén as Director	11/05/23	CI
Acarix CEO Joins Pharmacolog in Same Role	09/01/23	MT
Acarix : Nomination committee	11/04/22	PU
Acarix : newly appointed CEO Helen Ljundahl Round interview on strategic focus and execution (interview in Swedish)	21/01/22	PU
Acarix AB Appoints Helen Ljungdahl Round as New CEO	10/01/22	CI
Acarix Appoints Helen Ljungdahl Round as President Acarix Inc	28/09/21	CI
Acarix Recruits Helen Ljungdahl Round as Head of the Company’s Newly Established Us Subsidiary Acarix Inc	14/09/21	CI
Acarix AB Announces Board Changes	12/04/21	CI
Acarix AB Announces Executive Changes	14/05/20	CI
Acarix AB Announces Board Changes	20/05/19	CI
Acarix AB Appoints Per Perrson as Chief Executive Officer	13/11/18	CI
Acarix AB Recruits Per Persson as Chief Commercial Officer	23/05/18	CI

No results for this search